Search

everythinglearnresearchcommunity

for

Search:↓

The patient with lupus and Degos' disease showed significant improvement with treatment.

B cells can both help and hinder the body's defense against melanoma.

COVID-19 vaccination may trigger lupus in some people.

SLE patients experience hair loss similar to telogen effluvium, with hair damage and immune activity at hair follicles.

Human hair and nail proteins are unlikely to cause allergic reactions.

Severe acne patients have higher inflammatory markers than healthy people.

A woman got a skin condition from misusing a steroid cream, which improved after she stopped using it and started a new treatment.

A possible link exists between minimal change nephrotic syndrome and complete hair loss.

Tocilizumab might be an effective treatment for COVID-19.

Treatment restored normal sexual characteristics and blood condition in a patient with testicular cancer.

Dermal IgA deposition without symptoms is rare in Dermatitis herpetiformis risk groups.

The albumin change rate helps predict treatment success in AIDS-related non-Hodgkin lymphoma.

A man with HIV had hair loss due to syphilis, which improved after penicillin treatment.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Systemic lupus erythematosus is a complex autoimmune disease mainly affecting women, with varied symptoms and unknown exact cause.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Blood hormone levels don't accurately show brain hormone levels in males.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Prednisone reduces organ mast cell infiltration but does not alter the abnormal appearance of mast cells in systemic mastocytosis.

Mogamulizumab can cause hair loss and skin rashes.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

Fibroblasts can be mistaken for neural cells, so functional validation is needed.

Interferon α‐2b can temporarily reduce hepatitis C virus and normalize liver enzyme levels.

Serenoa repens is not proven effective for hair loss and may delay prostate cancer detection.

Serenoa repens is not proven effective for hair loss and may delay prostate cancer detection.

Negative expectations can cause adverse effects in patients even without active treatment, and managing this nocebo effect involves better communication and patient-clinician relationships.